Last reviewed · How we verify

NCT06945991

Application and Effect Evaluation of Integrated Nursing and Medical Management in Pediatric Lobar Pneumonia

Completed Last updated 27 April 2025
What this trial tests

trial testing observation group in Pediatrics in 50 participants. Completed in 18 October 2024.

Timeline
13 January 2023
Primary endpoint
20 March 2024
18 October 2024

Quick facts

Lead sponsorChildren's Hospital of Hebei Province
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date13 January 2023
Primary completion20 March 2024
Estimated completion18 October 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Hebei Province

Who can join

Adults 1 to 12, any sex, with Pediatrics or Lobar Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Integrated nursing and medical management significantly improves clinical symptoms and pulmonary function in children with lobar pneumonia, shortens hospitalization duration, reduces complication rates, and enhances caregiver satisfaction. These findings support its broad clinical applicability and value.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Integrated nursing and medical management improves outcomes in pediatric lobar pneumonia: a randomized controlled study.
    Hu Y, Guo Q, Liu X, Lv W, et al · · 2025 · PMID 40791810 · DOI 10.3389/fped.2025.1612618

Verify or expand the search:

Other trials of observation group

Trials testing the same drug.

Other recruiting trials for Pediatrics

Currently open trials in the same condition.

Other Children's Hospital of Hebei Province trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06945991.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing